Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The pressing need for a global HEV vaccine.
Peron JM, Larrue H, Izopet J, Buti M. Peron JM, et al. Among authors: buti m. J Hepatol. 2023 Sep;79(3):876-880. doi: 10.1016/j.jhep.2023.03.024. Epub 2023 Mar 30. J Hepatol. 2023. PMID: 37003442 Review.
HEVnet: a One Health, collaborative, interdisciplinary network and sequence data repository for enhanced hepatitis E virus molecular typing, characterisation and epidemiological investigations.
Mulder AC, Kroneman A, Franz E, Vennema H, Tulen AD, Takkinen J, Hofhuis A, Adlhoch C; Members of HEVnet. Mulder AC, et al. Euro Surveill. 2019 Mar;24(10):1800407. doi: 10.2807/1560-7917.ES.2019.24.10.1800407. Euro Surveill. 2019. PMID: 30862334 Free PMC article.
EASL Clinical Practice Guidelines on hepatitis delta virus.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, et al. J Hepatol. 2023 Aug;79(2):433-460. doi: 10.1016/j.jhep.2023.05.001. Epub 2023 Jun 24. J Hepatol. 2023. PMID: 37364791
OPTI-HEP-D: a protocol for an intervention study comprising screening and linkage to care of people living with hepatitis D in Catalonia.
Palom A, Rando-Segura A, Fernandez G, Calatayud L, Sellés-Sánchez A, Pérez Del Campo D, Mormeneo Bayo S, Perez Moreno MMO, Tabernero D, Ayats J, Llopis MA, Quer JC, Buti M. Palom A, et al. Among authors: buti m. BMJ Open. 2024 Nov 24;14(11):e086961. doi: 10.1136/bmjopen-2024-086961. BMJ Open. 2024. PMID: 39581731 Free article.
Hepatitis E as a trigger for Acute-on-Chronic Liver Failure.
Buti M, Ruiz-Cobo JC, Esteban R, Riveiro-Barciela M. Buti M, et al. Clin Mol Hepatol. 2024 Nov 11. doi: 10.3350/cmh.2024.0758. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39523715 Free article. Review.
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.
Buti M, Lim YS, Chan HLY, Agarwal K, Marcellin P, Brunetto MR, Chuang WL, Janssen HLA, Fung SK, Izumi N, Jablkowski MS, Abdurakhmanov D, Abramov F, Wang H, Botros I, Yee LJ, Mateo R, Flaherty JF, Osinusi A, Pan CQ, Shalimar X, Seto WK, Gane EJ. Buti M, et al. Aliment Pharmacol Ther. 2024 Sep 27. doi: 10.1111/apt.18278. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39327857
Implementing a new HCV model of care for people who use drugs.
Herranz Mochales A, Picchio CA, Nicolàs A, Macià MD, Fernández-Baca MV, Serrano J, Bonet L, Trelles M, Sansó A, Rubí AR, Zamora A, García-Gasalla M, Buti M, Vilella À, Lazarus JV. Herranz Mochales A, et al. Among authors: buti m. JHEP Rep. 2024 Jun 13;6(10):101145. doi: 10.1016/j.jhepr.2024.101145. eCollection 2024 Oct. JHEP Rep. 2024. PMID: 39308984 Free PMC article.
Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D.
Buti M, Calleja JL, Rodríguez MÁ, Domínguez-Hernández R, Cantero H, Espinoza-Cámac N, Casado MÁ. Buti M, et al. Gastroenterol Hepatol. 2024 Sep 7:502241. doi: 10.1016/j.gastrohep.2024.502241. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 39251019 Free article. English, Spanish.
656 results